JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
 QUICK SEARCH:   [advanced]


     


First published online April 15, 2008
J Nucl Med 2008, doi:10.2967/jnumed.107.046987
© 2008 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.107.046987v1
49/5/700    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frost, M. L.
Right arrow Articles by Fogelman, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frost, M. L.
Right arrow Articles by Fogelman, I.


Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism

Michelle L. Frost 1*, Glen M. Blake 1, So-Jin Park-Holohan 2, Gary J.R. Cook 3, Kathleen M. Curran 4, Paul K. Marsden 5, and Ignac Fogelman 1

1 King's College London, Osteoporosis Screening and Research Unit, Guy's Hospital, London, United Kingdom
2 Molecular Medicine Section, National Heart and Lung Institute, Imperial College, London, United Kingdom
3 Department of Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom
4 School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland
5 King's College London, PET Imaging Centre, St. Thomas' Hospital, London, United Kingdom

* To whom correspondence should be addressed. E-mail: michelle.frost{at}kcl.ac.uk.


   Abstract

18F-Fluoride PET allows noninvasive evaluation of regional bone metabolism and has the potential to become a useful tool for assessing patients with metabolic bone disease and evaluating novel drugs being developed for these diseases. The main PET parameter of interest, termed Ki, reflects regional bone metabolism. The aim of this study was to compare the long-term precision of 18F-fluoride PET with that of biochemical markers of bone turnover assessed over 6 mo. Methods: Sixteen postmenopausal women with osteoporosis or significant osteopenia and a mean age of 64 y underwent 18F-fluoride PET of the lumbar spine and measurements of biochemical markers of bone formation (bone-specific alkaline phosphatase and osteocalcin) and bone resorption (urinary deoxypyridinoline) at baseline and 6 mo later. Four different methods for analyzing the 18F-fluoride PET data were compared: a 4k 3-compartmental model using nonlinear regression analysis (Ki-4k), a 3k 3-compartmental model using nonlinear regression analysis (Ki-3k), Patlak analysis (Ki-PAT), and standardized uptake values. Results: With the exception of a small but significant decrease in Ki-3k at 6 mo, there were no significant differences between the baseline and 6-mo values for the PET parameters or biochemical markers. The long-term precision, expressed as the coefficient of variation (with 95% confidence interval in parentheses), was 12.2% (9%–19%), 13.8% (10%–22%), 14.4% (11%–22%), and 26.6% (19%–40%) for Ki-3k, Ki-PAT, mean standardized uptake value, and Ki-4k, respectively. For comparison, the precision of the biochemical markers was 10% (7%–15%), 18% (13%–27%), and 14% (10%–21%) for bone-specific alkaline phosphatase, osteocalcin, and urinary deoxypyridinoline, respectively. Intraclass correlation between the baseline and 6-mo values ranged from 0.44 for Ki-4k to 0.85 for Ki-3k. No significant correlation was found between the repeated mean standardized uptake value measurements. Conclusion: The precision and intraclass correlation observed for Ki-3k and Ki-PAT was equivalent to that observed for biochemical markers. This study provided initial data on the long-term precision of 18F-fluoride PET measured at the lumbar spine, which will aid in the accurate interpretation of changes in regional bone metabolism in response to treatment.

Key Words: 18F-fluoride PET, precision, bone metabolism, osteoporosis




This article has been cited by other articles:


Home page
JNMHome page
G. M. Blake, M. L. Frost, and I. Fogelman
Quantitative Radionuclide Studies of Bone
J. Nucl. Med., November 1, 2009; 50(11): 1747 - 1750.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.